<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03870516</url>
  </required_header>
  <id_info>
    <org_study_id>Speckle tracking echo</org_study_id>
    <nct_id>NCT03870516</nct_id>
  </id_info>
  <brief_title>Left Chamber Function in Mitral Regurgitation and Predicting Outcome After Replacement and Targeting for Early Surgery</brief_title>
  <official_title>Assessment of Subclinical Left Atrial and Left Ventricular Dysfunction by Speckle Tracking Echocardiography in Severe Asymptomatic Rheumatic Mitral Regurgitation and Its Role in Predicting Outcome After Valve Replacement Compared to Guideline Parameters</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to analyze the role of left ventricular and left atrial functional parameters
      by speckle tracking echocardiography in predicting outcome after mitral valve replacement and
      targeting for early intervention compared to guideline parameters.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Without surgical treatment, the 10-year morbidity and mortality for patients with severe
      mitral regurgitation can be as high as 90%.

      In contrast, with successful surgical correction of mitral regurgitation before the
      appearance of symptoms, patients may have life expectancies similar to that of the general
      population.

      According to European recommendations, mitral valve replacement must be proposed to
      symptomatic patients and to patients with significant left ventricular remodeling as a
      consequence of the severity of mitral regurgitation.

      A significant decline in left ventricular function is defined, in these recommendations,
      echocardiographically as an left ventricular ejection fraction &lt; 60% or an left ventricular
      end-systolic diameter &gt; 45 mm.

      Preoperative left ventricular systolic function and left ventricular end systolic diameter
      are important postoperative prognostic factors.

      The early detection of left ventricular systolic dysfunction remains a challenge. Mitral
      regurgitation causes low left ventricular afterload, and the ejection fraction thus remains
      normal or supernormal until the disease reaches an advanced stage.

      Some authors have suggested the additive value of deformation indices as more sensitive than
      the ejection fraction to detect subclinical left ventricular systolic dysfunction Speckle
      tracking echocardiography has been well validated as a quantitative assessment tool for left
      ventricular function, and more recently this technique has been described for assessment of
      regional and global left atrial function
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 20, 2021</start_date>
  <completion_date type="Anticipated">September 2023</completion_date>
  <primary_completion_date type="Anticipated">September 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patients with rheumatic severe mitral regurgitation</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recovery of left atrial functions (conduit, reservoir and booster contractile functions) and left ventricular function (global longitudinal strain) by speckle tracking echocardiography after mitral valve replacement</measure>
    <time_frame>6 months after surgery</time_frame>
    <description>Speckle tracking echocardiography will be performed 6 months after surgery to assess recovery of left atrial function by assessment of conduit, reservoir and booster contractile functions and left ventricular function by assessment of global longitudinal strain after mitral valve replacement</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of patients with major adverse cardiovascular events (MACE)</measure>
    <time_frame>6 months</time_frame>
    <description>Quantifying patients with CVD events, admission for HF, ischemic cardiovascular events, cardiac death, or MACE within 6 months after surgery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Mitral Regurgitation</condition>
  <arm_group>
    <arm_group_label>Valve replacement according to guideline parameters</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>One group will be referred for surgery according according to indications for mitral valve replacement in European guidelines for valvular heart diseases published in 2017 and will have speckle tracking echocardiography before surgery and 6 months later for comparison.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Early valve replacement</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The other group will include patients with severe asymptomatic mitral regurgitation who have left atrial or left ventricular dysfunction according to speckle tracking echocardiography and will be referred to surgery, then speckle tracking echo will be performed 6 months later.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Mitral valve replacement</intervention_name>
    <description>Replacing the diseased mitral valve in cases with severe mitral regurgitation with a prosthetic valve.</description>
    <arm_group_label>Early valve replacement</arm_group_label>
    <arm_group_label>Valve replacement according to guideline parameters</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Speckle tracking echocardiography</intervention_name>
    <description>We will perform Speckle tracking echocardiography in order to identify patients with early subclinical left ventricular or left atrial dysfunction and refer them to surgery, Then after surgery, speckle tracking echocardiography will be performed for all patients to assess improvement of left atrial (conduit, reservoir and booster contractile functions) and left ventricular (global longitudinal strain) function</description>
    <arm_group_label>Early valve replacement</arm_group_label>
    <arm_group_label>Valve replacement according to guideline parameters</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with rheumatic severe mitral regurgitation who will have mitral valve
             replacement in Assiut University Heart Hospital

        Exclusion Criteria:

          -  Degenerative mitral regurgitation, ischemic mitral regurgitation, severe rheumatic
             mitral regurgitation with atrial fibrillation or impaired left ventricular ejection
             fraction, associated mitral stenosis, or significant aortic regurgitation and ischemic
             heart disease.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hamdy Shamseddin, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mohamed M. Reda</last_name>
    <phone>01007041335</phone>
    <email>mreda30688@aun.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mohamed Abdelhafez, MD</last_name>
    <phone>01065889346</phone>
    <email>mohamed.abdelhafez@aun.edu.eg</email>
  </overall_contact_backup>
  <reference>
    <citation>Lancellotti P, Cosyns B, Zacharakis D, Attena E, Van Camp G, Gach O, Radermecker M, Pi√©rard LA. Importance of left ventricular longitudinal function and functional reserve in patients with degenerative mitral regurgitation: assessment by two-dimensional speckle tracking. J Am Soc Echocardiogr. 2008 Dec;21(12):1331-6. doi: 10.1016/j.echo.2008.09.023.</citation>
    <PMID>19041577</PMID>
  </reference>
  <reference>
    <citation>Marciniak A, Sutherland GR, Marciniak M, Kourliouros A, Bijnens B, Jahangiri M. Prediction of postoperative left ventricular systolic function in patients with chronic mitral regurgitation undergoing valve surgery--the role of deformation imaging. Eur J Cardiothorac Surg. 2011 Nov;40(5):1131-7. doi: 10.1016/j.ejcts.2011.02.049. Epub 2011 Apr 1.</citation>
    <PMID>21459016</PMID>
  </reference>
  <reference>
    <citation>Vianna-Pinton R, Moreno CA, Baxter CM, Lee KS, Tsang TS, Appleton CP. Two-dimensional speckle-tracking echocardiography of the left atrium: feasibility and regional contraction and relaxation differences in normal subjects. J Am Soc Echocardiogr. 2009 Mar;22(3):299-305. doi: 10.1016/j.echo.2008.12.017.</citation>
    <PMID>19258177</PMID>
  </reference>
  <reference>
    <citation>Cameli M, Caputo M, Mondillo S, Ballo P, Palmerini E, Lisi M, Marino E, Galderisi M. Feasibility and reference values of left atrial longitudinal strain imaging by two-dimensional speckle tracking. Cardiovasc Ultrasound. 2009 Feb 8;7:6. doi: 10.1186/1476-7120-7-6.</citation>
    <PMID>19200402</PMID>
  </reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>March 8, 2019</study_first_submitted>
  <study_first_submitted_qc>March 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 12, 2019</study_first_posted>
  <last_update_submitted>May 22, 2020</last_update_submitted>
  <last_update_submitted_qc>May 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Mohamed M. Reda Abdelaziz</investigator_full_name>
    <investigator_title>physician</investigator_title>
  </responsible_party>
  <keyword>mitral</keyword>
  <keyword>regurgitation</keyword>
  <keyword>speckle</keyword>
  <keyword>echocardiography</keyword>
  <keyword>replacement</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitral Valve Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

